Posted on April 28, 2026 in Immigration and Employer Sponsorship

If you are a medical professional who wants to come to the United States for training, residency, or a fellowship program, the J-1 visa is most likely the path you will take. It is the most common visa used by international medical graduates entering training programs here. But the J-1 visa comes with specific rules and a major restriction called the two-year home residency requirement. Every applicant needs to understand this before they begin.

Our New York City employment-based immigration lawyers can help you navigate the process, plan for what comes after your program, and figure out your options if the two-year requirement creates problems for your career.

What Is the J-1 Visa and Who Can Get One?

The J-1 visa is for people who come to the United States to take part in approved educational and cultural exchange programs. For medical professionals, it is most often used by physicians entering residency or fellowship programs accredited by the Accreditation Council for Graduate Medical Education, known as ACGME.

Continue Reading ››

 Posted on April 15, 2026 in Healthcare Compliance & Risk Advisory

Running a med spa in New York involves more than offering services and building a client base. It means following a specific set of legal rules governing who can perform medical procedures, how and when physicians must be involved, and how the business must be set up to be legal. Getting these things wrong can lead to investigations, fines, license revocations, or forced closure. If you are starting or operating a med spa in 2026, our New York City business compliance and risk advisory lawyers can help you build a structure that protects your business and everyone in it.

The Role of a Supervising Physician in a New York Med Spa

New York law requires that a licensed physician perform or supervise certain medical procedures at a med spa. But supervision does not just mean having a doctor available by phone. The level of oversight required depends on the procedure and the credentials of the person performing it.

Continue Reading ››

 Posted on April 04, 2026 in AI Governance and Data Privacy

If you are developing or implementing an AI-powered medical device in 2026, understanding how the FDA classifies it is one of the first steps toward getting it to market or legally putting it into use. The classification your device gets determines how much oversight is required, what you need to submit to the FDA, and how long the process will take. Getting this wrong can cost you time and money, whether you are building the device or deploying it in a clinical setting. Our New York City AI governance lawyers can help you figure out where your device fits and what you need to do next.

How Does the FDA Define an AI Medical Device?

The FDA defines a medical device under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 321(h), as any instrument or software meant to diagnose, treat, cure, prevent, or reduce a disease or condition. Software that uses artificial intelligence or machine learning to do any of those things is called software as a medical device, or SaMD, and falls under FDA oversight.

Continue Reading ››